ESR1 and breast carcinoma: This correlation was highly significant with breast cancers expressing estrogen receptor (ER+) or exhibiting lymph node metastasis (LN+) (Figure 5A–C) and was lower but still significant in breast cancers with ER− and LN− status (Figure S5A and B).